メニュー 戻るLS28 Discussion with Patients about Rare Disease Drug Development to Improve Drug Lag in Japan
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
19th DIA Japan Annual Meeting 2022
LS28 Discussion with Patients about Rare Disease Drug Development to Improve Drug Lag in Japan
Harumasa Nakamura, MD, PhD
- Director of Clinical Research Support Office, Translational Medical Center
- National Center of Neurology and Psychiatry, Japan
- Japan Development Leader, Clinical Research, Rare Disease
- Pfizer R&D Japan, Japan
- Head of Plasma-Derived Therapies Strategy Unit
- Takeda Pharmaceutical Company Limited, Japan
Kosuke Ito, PhD
- Principal Reviewer
- Pharmaceuticals and Medical Devices Agency (PMDA), Japan